EV/EBITDA
-4.43
+0.01+0.23%
22 min ago
Summary:
Silence Therapeutics EV/EBITDA is currently -4.43, with a rise of +0.01 (+0.23%) during the most recent trading day. Over the past year, it has increased by +3.80 (+46.17%). SLN EV/EBITDA is now -142.08% below its all-time high of -1.83.SLN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLN EV/EBITDA Performance
PeriodPeriod | EV/EBITDAEV/EBITDA |
---|---|
todaytoday | +0.2% |
1 m1 month | +57.1% |
3 m3 months | +60.2% |
6 m6 months | +68.8% |
ytdytd | +57.2% |
1 y1 year | +46.2% |
5 y5 years | - |
SLN EV/EBITDA High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | -3.26 | -35.9% | -10.63 | +58.3% |
3 m | 3 months | -3.26 | -35.9% | -11.71 | +62.2% |
6 m | 6 months | -3.26 | -35.9% | -15.27 | +71.0% |
1 y | 1 year | -3.26 | -35.9% | -19.74 | +77.6% |
3 y | 3 years | -1.83 | -142.1% | -19.74 | +77.6% |
5 y | 5 years | -1.83 | -142.1% | -25.27 | +82.5% |
alltime | all time | -1.83 | -142.1% | -25.27 | +82.5% |
Silence Therapeutics EV/EBITDA History
Date | Value |
---|---|
2024 | -4.43(-57.2%) |
2023 | -10.36(+24.1%) |
Date | Value |
---|---|
2022 | -8.35(-16.2%) |
2021 | -9.96(-49.1%) |
2020 | -19.58 |
FAQ
- What is Silence Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Silence Therapeutics?
- What is SLN EV/EBITDA year-to-date change?
- What is Silence Therapeutics EV/EBITDA year-on-year change?
What is Silence Therapeutics EV/EBITDA?
The current EV/EBITDA of SLN is -4.43
What is the all time high EV/EBITDA for Silence Therapeutics?
Silence Therapeutics all-time high EV/EBITDA is -1.83
What is SLN EV/EBITDA year-to-date change?
Silence Therapeutics EV/EBITDA has changed by +5.93 (+57.24%) since the beginning of the year
What is Silence Therapeutics EV/EBITDA year-on-year change?
Over the past year, SLN EV/EBITDA has changed by +3.80 (+46.17%)